Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation.: Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility

被引:71
|
作者
Le Ray, AM [1 ]
Chiffoleau, S [1 ]
Iooss, P [1 ]
Grimandi, G [1 ]
Gouyette, A [1 ]
Daculsi, G [1 ]
Merle, C [1 ]
机构
[1] INSERM, Equipe 99 03, Ctr Rech Mat Interet Biol, Pharm Galen Lab, F-44042 Nantes, France
关键词
microparticles; poly(epsilon-caprolactone); vancomycin; solvent evaporation process; in vitro release; cytocompatibility;
D O I
10.1016/S0142-9612(02)00357-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles (200 mum mean diameter) was most efficient with a simple emulsion technique that dispersed 122.5 mg/g of polymer. Scanning electron micrographs showed smooth or pitted particles. Dissolution studies were correlated with microparticle morphology, indicating higher release with pitted particles when vancomycin was encapsulated in a dissolved state. The cytocompatibility of these poly(epsilon-caprolactone) microparticles was demonstrated by a direct contact cytotoxic assay. This material can be considered as an efficient drug delivery system for bone implantation. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 3 条